Share

AstraZeneca halts COVID-19 vaccine trial for safety review

A major vaccine trial by British-Swedish drugmaker AstraZeneca was halted due to a serious adverse reaction by a participant in the trials.
Wed, 09 Sep 2020 08:47:40 GMT
Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.